Main > RHEUMATOLOGY > USA. E. RA>Treat.>JAK Inhibitor Tab

---

USA. E. RA>Treat.>JAK Inhibitor Tab's subsections
(*) EU Approval Date: 2017. 02.13.
(*) JP Approval Date: 2017. 07.03.
(*) USA Approval Date: 2018. 06.01.
Company
Generic Name: Baricitinib.
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 10.19
RTM
RTM Web-Site

USA. E. RA>Treat.>JAK Inhibitor Tab's products
This section has no products